Drug Patent Expirations in November 2011

Drug Patent Expirations in November 2011

*Drugs may be covered by multiple patents

TradenameApplicantGeneric NamePatent NumberPatent Expiration
APHTHASOLUluruamlexanox5,362,737Nov 8, 2011
MAGNEVISTBayer Hlthcaregadopentetate dimeglumine5,362,475Nov 8, 2011
ABLAVARLantheus Medclgadofosveset trisodium5,362,475Nov 8, 2011
OMNISCANGe Healthcaregadodiamide5,362,475Nov 8, 2011
SYMBICORTAstrazenecabudesonide; formoterol fumarate dihydrate5,349,945Nov 12, 2011
CARDIZEM CDValeant Intldiltiazem hydrochloride5,364,620Nov 14, 2011
VFENDPfizervoriconazole5,364,938Nov 15, 2011
VISIPAQUE 270Ge Healthcareiodixanol5,366,722Nov 22, 2011
CHLORAPREP ONE-STEP FREPPCarefusionchlorhexidine gluconate; isopropyl alcoholD386849Nov 25, 2011
BAYCOLBayer Pharmscerivastatin sodium5,177,080Nov 26, 2011
TESLASCANGe Healthcaremangafodipir trisodium4,933,456Nov 27, 2011
ZOLINZAMerckvorinostatRE38506Nov 29, 2011

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

Courtesy of DrugPatentWatch.com


Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog